Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07238478 · ClinicalTrials.gov registry record · NA
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
A NA study of Hot Flashes and Joint Pain, sponsored by Bonafide Health.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT07238478: Recruiting NA study of Hot Flashes and Joint Pain, sponsored by Bonafide Health.
NCT07238478 is a NA study of Hot Flashes and Joint Pain that is actively recruiting participants, run by Bonafide Health. The registered enrollment target is 250 participants, above the 161-participant average among 23 other Hot Flashes trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07238478, a NA study of Hot Flashes and Joint Pain, is actively recruiting participants, sponsored by Bonafide Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.
Primary Outcome
Change from baseline in scores for severity of perceived joint discomfort, frequency of perceived joint discomfort, perceived joint mobility and perceived daily mobility assessed via a Visual Analog Scale (VAS). Response options will range from 0-100, with a higher score reflecting the worse outcome.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT JDS-HF3.0
Study Locations (1)
New York
- Bonafide Health - Harrison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07238478 shows while recruiting
NCT07238478 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 161-participant average among 23 other Hot Flashes trials with a reported enrollment target (55% higher).
The record links to 7 conditions, with Hot Flashes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07238478 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07238478 about?
NCT07238478 is a clinical study titled "JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women". The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for...
What is the current status of trial NCT07238478?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-05-14. Estimated completion is 2026-10.
What conditions does trial NCT07238478 study?
This clinical trial studies the following conditions: Hot Flashes, Joint Pain, Vasomotor Symptoms, Night Sweats, Joint Discomfort.
What interventions are being tested in trial NCT07238478?
The interventions under investigation include: Placebo (OTHER), JDS-HF3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07238478?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07238478 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hot Flashes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07238478's enrollment target sits among peer trials
250 4th of 23 higher than 20 of 23 other Hot Flashes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hot Flashes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
COMPLETED · NA
-
Reducing the Experience of Menopausal Symptoms Through Temperature
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI